Cyclopentanesulfonyl chloride → N-({4-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]phenyl}methyl)cyclopentanesulfonamide
반응식
[F:1][C:2]([F:21])([F:20])[C:3]1[C:11]2[CH2:10][CH2:9][CH2:8][CH2:7][C:6]=2[N:5]([C:12]2[CH:17]=[CH:16][C:15]([CH2:18][NH2:19])=[CH:14][CH:13]=2)[N:4]=1.[CH:22]1([S:27](Cl)(=[O:29])=[O:28])[CH2:26][CH2:25][CH2:24][CH2:23]1>>[F:21][C:2]([F:1])([F:20])[C:3]1[C:11]2[CH2:10][CH2:9][CH2:8][CH2:7][C:6]=2[N:5]([C:12]2[CH:17]=[CH:16][C:15]([CH2:18][NH:19][S:27]([CH:22]3[CH2:26][CH2:25][CH2:24][CH2:23]3)(=[O:29])=[O:28])=[CH:14][CH:13]=2)[N:4]=1참가 물질
3
실험 절차
The title compound was prepared from ({4-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]phenyl}methyl)amine and cyclopentanesulphonyl chloride using a similar procedure to that described for Example 88.
출처 및 근거
- ORD 기록
- ord-4e72fabdb95a4a69a13bde4573fa46cf
- 출처 데이터셋
- uspto-grants-2009_07